Consolidated Statements of Earnings (USD $) In Millions, except Per Share data, unless otherwise specified	12 Months Ended
	Jun. 30, 2013		Jun. 30, 2012	Jun. 30, 2011
Income Statement [Abstract]
Revenue	$ 101,093		$ 107,552	$ 102,644
Cost of products sold	96,172		103,011	98,482
Gross margin	4,921		4,541	4,162
Operating expenses:
Distribution, selling, general and administrative expenses	2,875		2,677	2,528
Restructuring and employee severance	71	[1]	21	15
Acquisition-related costs	158		33	90
Impairments and loss on disposal of assets	859		21	9
Litigation (recoveries)/charges, net	(38)		(3)	6
Operating earnings	996		1,792	1,514
Other income, net	(15)		(1)	(22)
Interest expense, net	123		95	93
Gain on sale of investment in CareFusion	0		0	(75)
Earnings before income taxes and discontinued operations	888		1,698	1,518
Provision for income taxes	553		628	552
Earnings from continuing operations	335		1,070	966
Loss from discontinued operations, net of tax	(1)		(1)	(7)
Net earnings	$ 334		$ 1,069	$ 959
Basic earnings/(loss) per common share:
Continuing operations	$ 0.98		$ 3.10	$ 2.77
Discontinued operations	$ 0.00		$ 0.00	$ (0.02)
Net basic earnings per common share	$ 0.98		$ 3.10	$ 2.75
Diluted earnings/(loss) per common share:
Continuing operations	$ 0.97		$ 3.06	$ 2.74
Discontinued operations	$ 0.00		$ 0.00	$ (0.02)
Net diluted earnings per common share	$ 0.97		$ 3.06	$ 2.72
Weighted-average number of common shares outstanding:
Basic	341		345	349
Diluted	344		349	353

[1] Includes $30 million of employee-related costs and $10 million of facility exit and other costs related to the restructuring within our Medical segment described further below.